Evidence map›Paper›PMID 39695145›Full record

ArticleNature communications2024

Design of pseudosymmetric protein hetero-oligomers.

Ryan D Kibler, Sangmin Lee, Madison A Kennedy, Basile I M Wicky, Stella M Lai, Marius M Kostelic, Ann Carr, Xinting Li, Cameron M Chow, Tina K Nguyen and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Reverse-engineering amyloid strains with generative protein design.bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Rapid and automated design of two-component protein nanomaterials using ProteinMPNN.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Ryan D KiblerDepartment of Biochemistry, University of Washington, Seattle, WA, 98195, USA.ORCID http://orcid.org/0000-0001-6984-9887
Sangmin LeeDepartment of Biochemistry, University of Washington, Seattle, WA, 98195, USA.ORCID http://orcid.org/0000-0002-1145-4708
Madison A KennedyDepartment of Biochemistry, University of Washington, Seattle, WA, 98195, USA.
Basile I M WickyDepartment of Biochemistry, University of Washington, Seattle, WA, 98195, USA.ORCID http://orcid.org/0000-0002-2501-7875
Stella M LaiDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, 43210, USA.ORCID http://orcid.org/0000-0001-7107-0629
Marius M KostelicDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, 43210, USA.
Ann CarrDepartment of Biochemistry, University of Washington, Seattle, WA, 98195, USA.
Xinting LiDepartment of Biochemistry, University of Washington, Seattle, WA, 98195, USA.
Cameron M ChowDepartment of Biochemistry, University of Washington, Seattle, WA, 98195, USA.ORCID http://orcid.org/0000-0001-5351-6412
Tina K NguyenDepartment of Biochemistry, University of Washington, Seattle, WA, 98195, USA.ORCID http://orcid.org/0009-0001-8385-0275
Lauren CarterDepartment of Biochemistry, University of Washington, Seattle, WA, 98195, USA.
Vicki H WysockiDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, 43210, USA.ORCID http://orcid.org/0000-0003-0495-2538
Barry L StoddardDivision of Basic Sciences, Fred Hutchinson Cancer Center, Seattle, WA, 98006, USA.ORCID http://orcid.org/0000-0003-2250-9601
David BakerDepartment of Biochemistry, University of Washington, Seattle, WA, 98195, USA. dabaker@uw.edu.ORCID http://orcid.org/0000-0001-7896-6217

Funding

User Training and OutreachP30GM124169 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI PAUL David ADAMS, Gregory L Hura · 2017 to 2026
$28.6M
Waters Select Series Cyclic IMS for P41 Native MS Resource Application to Alzheimer's DiseaseP41GM128577 · NIGMS · OHIO STATE UNIVERSITY · PI WYSOCKI, VICKI H. · 2018 to 2022
$7.6M
Native Mass Spectrometry Guided Structural Biology CenterRM1GM149374 · NIGMS · OHIO STATE UNIVERSITY · PI Vicki H. Wysocki · 2023 to 2026
$5.0M
MegaTALS: hyperspecific reagents for targeted gene modification and correctionR01GM105691 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STODDARD, BARRY L. · 2014 to 2022
$2.7M
Biophysical and structural studies of protein and enzyme mechanism, evolution, and engineeringR35GM148166 · NIGMS · FRED HUTCHINSON CANCER CENTER · PI BARRY L. STODDARD · 2023 to 2026
$2.3M
Combined computational and structural studies to create novel macromolecular recognition propertiesR01GM139752 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STODDARD, BARRY L. · 2021 to 2023
$1.1M
A Pixel Array Detector System for Small Angle X-ray ScatteringS10OD018483 · OD · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI CLASSEN, SCOTT · 2014 to 2014
$998k
Pilatus 6mS10OD021832 · OD · UNIVERSITY OF CALIFORNIA BERKELEY · PI ADAMS, PAUL DAVID · 2016 to 2016
$980k
Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) #OPP1156262European Molecular Biology Organization (EMBO) ALTF 139-2018Gates Foundation INV-010680National Science Foundation (NSF) DGE-1762114NIAID NIH HHS HHSN272201700059CNIGMS NIH HHS P30 GM124169NIGMS NIH HHS P41 GM128577NIGMS NIH HHS R01 GM105691NIGMS NIH HHS R01 GM139752NIGMS NIH HHS R35 GM148166NIGMS NIH HHS RM1 GM149374NIH HHS S10 OD018483NIH HHS S10 OD021832U.S. Department of Health & Human Services | National Institutes of Health (NIH) shared instrumentation grant S10OD021832
6 · The paper itself

Abstract

Pseudosymmetric hetero-oligomers with three or more unique subunits with overall structural (but not sequence) symmetry play key roles in biology, and systematic approaches for generating such proteins de novo would provide new routes to controlling cell signaling and designing complex protein materials. However, the de novo design of protein hetero-oligomers with three or more distinct chains with nearly identical structures is a challenging unsolved problem because it requires the accurate design of multiple protein-protein interfaces simultaneously. Here, we describe a divide-and-conquer approach that breaks the multiple-interface design challenge into a set of more tractable symmetric single-interface redesign tasks, followed by structural recombination of the validated homo-oligomers into pseudosymmetric hetero-oligomers. Starting from de novo designed circular homo-oligomers composed of 9 or 24 tandemly repeated units, we redesigned the inter-subunit interfaces to generate 19 new homo-oligomers and structurally recombined them to make 24 new hetero-oligomers, including ABC heterotrimers, A2B2 heterotetramers, and A3B3 and A2B2C2 heterohexamers which assemble with high structural specificity. The symmetric homo-oligomers and pseudosymmetric hetero-oligomers generated for each system have identical or nearly identical backbones, and hence are ideal building blocks for generating and functionalizing larger symmetric and pseudosymmetric assemblies.

Indexed as

Protein MultimerizationModels, MolecularProtein EngineeringProteinsProtein SubunitsProteinsProtein Subunits

Identifiers

PMID39695145
PMCPMC11655659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.